Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) does about 6.83M shares in volume on a normal day but saw 2350733 shares change hands in the recent trading day. The company now has a market cap of 9.25M USD. Its current market price is $0.29, marking a decrease of -22.64% compared to the previous close of $0.38. The 52 week high reached by this stock is $3.28 whilst the lowest price level in 52 weeks is $0.26.
Redhill Biopharma Ltd. ADR (RDHL) has a 20-day trading average at $0.4299 and the current price is -91.16% off the 52-week high compared with 12.88% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.4031 and its 200-day simple moving average is $0.6372. If we look at the stock’s price movements over the week, volatility stands at 14.95%, which increases to 16.67% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 39.98 to suggest the stock is neutral.
The consensus objective for the share price is $40.00, suggesting that the stock has a potential upside of 99.28% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 31, 2021 when Cantor Fitzgerald initiated the stock to “Overweight” and issued a price target of $22.
Redhill Biopharma Ltd. ADR (RDHL) stock is down -30.68% over the week and -21.72% over the past month. Its price is -80.13% year-to-date and -64.62% over the past year.
To reach the target analysts have set, the stock logically needs to grow 99.28 percent from here.
The company has a return on investment of 255.09%. The beta has a value of 3.68. Price to book ratio is 0.33 and price to sales ratio is 0.26.
